ISPE Puts a Spotlight on the Trending Industry Initiative Pharma 4.0(TM)

NORTH BETHESDA, Md., Aug. 21, 2019 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) announced their 2019 ISPE Europe Pharma 4.0(TM) Conference, taking place 20-21 November in Manchester, United Kingdom.

Pharma 4.0(TM) is a trending industry initiative that highlights the impact and benefit of digitalisation in pharma operations and production. Digitalisation of pharma manufacturing can propel the industry forward and facilitate technological, economical, and logistical advancement. ISPE has created a Pharma 4.0(TM) operating model to anticipate the industry's future by incorporating Pharma 4.0(TM)'s strategies for business and technology.

The 2019 ISPE Europe Pharma 4.0(TM) Conference features top business leaders and technical experts that will elaborate on new strategies and best practises for production operations of crucial systems with an information technology point of view. The educational agenda and conversations will focus on industry business becoming more affordable and efficient with Pharma 4.0(TM).

Featured Speakers:

    --  Lawrence Yu, PhD, Deputy Director, Office of Pharmaceutical Quality,
        FDA/CDER/OPQ
    --  Kevin Bailey, GMP Inspector, MHRA
    --  Christian Woelbeling, Senior Director Global Accounts, Werum IT
        Solutions
    --  Teresa Minero, Founder & CEO, Life Bee Srl
    --  Gareth Alford, Lead Engineer, GSK

To explore the agenda and to register, please visit http://www.ISPE.org/2019-EU-Pharma-40.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world's largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Amy Henry
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-813-960-2105
Email: ahenry(at)ispe(dot)org
http://www.ISPE.org

SOURCE International Society for Pharmaceutical Engineering (ISPE)